Eikon Therapeutics, Inc. Common Stock
NASDAQ: EIKN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Roger Perlmutter
- Employees
- 484
- Headquarters
- Millbrae, United States
- IPO year
- 2026
- Market cap
- $36.1M
- Website
- https://eikontx.com
Loading EIKN…
Loading profile data…Frequently asked questions about EIKN
What does Eikon Therapeutics, Inc. Common Stock (EIKN) do?
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing pro...
Where does EIKN trade?
Eikon Therapeutics, Inc. Common Stock (EIKN) trades on the NASDAQ Global Market.
What sector is EIKN in?
Eikon Therapeutics, Inc. Common Stock (EIKN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Eikon Therapeutics, Inc. Common Stock?
Roger Perlmutter is the chief executive officer of Eikon Therapeutics, Inc. Common Stock (EIKN).
Where is Eikon Therapeutics, Inc. Common Stock headquartered?
Eikon Therapeutics, Inc. Common Stock is headquartered in United States.
Does EIKN pay a dividend?
Eikon Therapeutics, Inc. Common Stock (EIKN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EIKN go public?
Eikon Therapeutics, Inc. Common Stock (EIKN) completed its initial public offering in 2026.